| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| SLP(L) | 148 | 90.8% | -0.89 | 80 | 92.0% |
| SCL(L) | 8 | 4.9% | -1.00 | 4 | 4.6% |
| LH(L) | 4 | 2.5% | -0.42 | 3 | 3.4% |
| CentralBrain-unspecified | 3 | 1.8% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns CB4131 | % In | CV |
|---|---|---|---|---|---|
| LHAV2h1 (L) | 2 | ACh | 12 | 7.8% | 0.7 |
| LHAV3b13 (L) | 2 | ACh | 9 | 5.8% | 0.8 |
| CB2701 (L) | 1 | ACh | 7 | 4.5% | 0.0 |
| LHAV4d1 (L) | 2 | unc | 7 | 4.5% | 0.7 |
| CB1500 (L) | 1 | ACh | 6 | 3.9% | 0.0 |
| SLP363 (L) | 1 | Glu | 6 | 3.9% | 0.0 |
| SLP202 (L) | 1 | Glu | 6 | 3.9% | 0.0 |
| SLP243 (L) | 1 | GABA | 6 | 3.9% | 0.0 |
| CB2467 (L) | 1 | ACh | 5 | 3.2% | 0.0 |
| CB2148 (L) | 2 | ACh | 5 | 3.2% | 0.6 |
| LHPV4d10 (L) | 3 | Glu | 5 | 3.2% | 0.6 |
| CB1604 (L) | 2 | ACh | 4 | 2.6% | 0.0 |
| DNp32 (L) | 1 | unc | 3 | 1.9% | 0.0 |
| LHPV7a1 (L) | 1 | ACh | 3 | 1.9% | 0.0 |
| CB0973 (L) | 1 | Glu | 3 | 1.9% | 0.0 |
| SLP315 (L) | 1 | Glu | 3 | 1.9% | 0.0 |
| CB1238 (L) | 1 | ACh | 3 | 1.9% | 0.0 |
| LHAV5a9_a (L) | 1 | ACh | 3 | 1.9% | 0.0 |
| CB2442 (L) | 1 | ACh | 3 | 1.9% | 0.0 |
| SLP364 (L) | 1 | Glu | 3 | 1.9% | 0.0 |
| SLP208 (L) | 1 | GABA | 3 | 1.9% | 0.0 |
| LHPV1c1 (R) | 2 | ACh | 3 | 1.9% | 0.3 |
| CB4084 (L) | 1 | ACh | 2 | 1.3% | 0.0 |
| LHAV3e5 (L) | 1 | ACh | 2 | 1.3% | 0.0 |
| SMP169 (L) | 1 | ACh | 2 | 1.3% | 0.0 |
| CB1901 (L) | 1 | ACh | 2 | 1.3% | 0.0 |
| SLP285 (L) | 1 | Glu | 2 | 1.3% | 0.0 |
| M_lvPNm38 (L) | 1 | ACh | 2 | 1.3% | 0.0 |
| SMP170 (L) | 1 | Glu | 2 | 1.3% | 0.0 |
| AVLP317 (L) | 1 | ACh | 2 | 1.3% | 0.0 |
| CB1154 (L) | 2 | Glu | 2 | 1.3% | 0.0 |
| SLP438 (L) | 1 | unc | 1 | 0.6% | 0.0 |
| LHPV5j1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB3556 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHCENT2 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| SLP252_b (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB2530 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| LHPV5b1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB2693 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHAV6a5 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHPD4b1 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB1212 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB1352 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| LHAV3n1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CL359 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB0367 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| LHPV4l1 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| LHAV4j1 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| SLP224 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHAV1f1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB0650 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| LHAV3a1_c (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB1608 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| PPL203 (L) | 1 | unc | 1 | 0.6% | 0.0 |
| mAL4I (R) | 1 | Glu | 1 | 0.6% | 0.0 |
| AVLP315 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| MBON20 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| PPL201 (L) | 1 | DA | 1 | 0.6% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.6% | 0.0 |
| downstream partner | # | NT | conns CB4131 | % Out | CV |
|---|---|---|---|---|---|
| LHAV6a5 (L) | 1 | ACh | 8 | 5.6% | 0.0 |
| LHAV6b3 (L) | 4 | ACh | 8 | 5.6% | 0.4 |
| CB1073 (L) | 1 | ACh | 7 | 4.9% | 0.0 |
| LHAV4e4 (L) | 2 | unc | 7 | 4.9% | 0.7 |
| LHPV5b6 (L) | 1 | ACh | 6 | 4.2% | 0.0 |
| LHAD1k1 (R) | 1 | ACh | 6 | 4.2% | 0.0 |
| SLP274 (L) | 1 | ACh | 5 | 3.5% | 0.0 |
| SLP377 (L) | 1 | Glu | 4 | 2.8% | 0.0 |
| LHAV5a8 (L) | 1 | ACh | 4 | 2.8% | 0.0 |
| SLP378 (L) | 1 | Glu | 3 | 2.1% | 0.0 |
| CB2693 (L) | 1 | ACh | 3 | 2.1% | 0.0 |
| CB2600 (L) | 1 | Glu | 3 | 2.1% | 0.0 |
| LHAD1k1 (L) | 1 | ACh | 3 | 2.1% | 0.0 |
| SLP376 (L) | 1 | Glu | 3 | 2.1% | 0.0 |
| LHPV5e1 (L) | 1 | ACh | 2 | 1.4% | 0.0 |
| SLP255 (L) | 1 | Glu | 2 | 1.4% | 0.0 |
| SLP429 (L) | 1 | ACh | 2 | 1.4% | 0.0 |
| PAM11 (L) | 1 | DA | 2 | 1.4% | 0.0 |
| SLP312 (L) | 1 | Glu | 2 | 1.4% | 0.0 |
| CB3477 (L) | 1 | Glu | 2 | 1.4% | 0.0 |
| CB1035 (L) | 1 | Glu | 2 | 1.4% | 0.0 |
| SLP012 (L) | 1 | Glu | 2 | 1.4% | 0.0 |
| LoVP82 (L) | 1 | ACh | 2 | 1.4% | 0.0 |
| CB1337 (L) | 1 | Glu | 2 | 1.4% | 0.0 |
| LHPD3c1 (L) | 1 | Glu | 2 | 1.4% | 0.0 |
| CB0947 (L) | 1 | ACh | 2 | 1.4% | 0.0 |
| SLP281 (L) | 1 | Glu | 2 | 1.4% | 0.0 |
| AVLP596 (L) | 1 | ACh | 2 | 1.4% | 0.0 |
| LHAV1f1 (L) | 1 | ACh | 2 | 1.4% | 0.0 |
| LHAV3b13 (L) | 1 | ACh | 2 | 1.4% | 0.0 |
| DA3_adPN (L) | 1 | ACh | 2 | 1.4% | 0.0 |
| CB2048 (L) | 2 | ACh | 2 | 1.4% | 0.0 |
| CB4086 (L) | 2 | ACh | 2 | 1.4% | 0.0 |
| LHPD4b1 (L) | 2 | Glu | 2 | 1.4% | 0.0 |
| AVLP443 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| LC40 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB3168 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| LHAV5a4_c (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB3121 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| LHPV4i4 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| CB1931 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| SLP164 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB1924 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| LHPD2c2 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| LHPV4d3 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| CB1289 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| LHPV4d4 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| SLP103 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| CB1590 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| SLP289 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| SLP038 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB3357 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB2298 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| SMP444 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| CB2805 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| SLP314 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| CB2172 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB1308 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| CB0650 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| SMP503 (L) | 1 | unc | 1 | 0.7% | 0.0 |
| SLP067 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| LHPV10c1 (L) | 1 | GABA | 1 | 0.7% | 0.0 |
| SLP070 (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| SLP243 (L) | 1 | GABA | 1 | 0.7% | 0.0 |
| SMP550 (L) | 1 | ACh | 1 | 0.7% | 0.0 |
| MBON20 (L) | 1 | GABA | 1 | 0.7% | 0.0 |
| LHCENT10 (L) | 1 | GABA | 1 | 0.7% | 0.0 |
